Healthcare treatment comparison software provider WiserTogether has completed raising its Series B funding of $9 million. Martin Ventures and Merck Global Health Innovation Fund (Merck GHI) led the round, with participation of all prior institutional investors, including the company’s founder and CEO Shub Debgupta, as well as Grotech Ventures, Harbert Venture Partners, 7Wire Ventures and Blue Heron Capital participated in the round.
“To win in healthcare today, and in the future, you must support and enable better decisions,” said Shub Debgupta, Chief Executive Officer, WiserTogether. “Those who better understand (and predict) those decisions will have a substantial advantage over the competition and will benefit from the emerging payment structures.”
Martin Ventures and Merck Global Health Innovation Fund led the round, with participation of all prior institutional investors.WiserTogether’s personalized healthcare comparison software enables consumers to compare over 4,000 of the highest cost treatments using personal, financial and clinical factors and to engage with the right treatment. The result is improved health and improved costs.
The company’s treatment comparison software combines unique data, algorithms and patent-pending decision models, and integrates with leading cost transparency solutions, provider search directories and content providers to create an award-winning and powerful consumer decision experience.
WiserTogether will use the new funds to scale its operations and expand its customer base across key sectors of healthcare.